Clindamycin

Drug ingredientActive Shortage

CAS 18323-44-9

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

US productionNot reported

Import value, 2024$546M

Top sourceItaly 41%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 294190 · basket

These shares come from HS customs code 294190, which covers 90 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries

Country of origin for US imports, from Census customs data (2024).

IT 41%ItalyCN 24%ChinaDK 9%DenmarkHR 6%CroatiaIN 6%India

United Kingdom
Slovakia
Slovenia
Mexico
Canada
Germany
Belgium
Japan
Switzerland
Netherlands
Czech Republic
Uruguay
South Korea
Hong Kong
Portugal
Australia

3 FDA-registered drug labelers

Civica, Inc.

Hikma Pharmaceuticals USA Inc.

Sandoz Inc

Why It Matters

Sectors

Health

Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

•Clindamycin in 5 Percent Dextrose

FDA Shortage Status

Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."

Active Shortage

Shortage History

Rows group FDA shortage filings by drug product. Each manufacturer makes its own FDA shortage filing, so one product can carry several reports at once: Available, Limited Availability, Unavailable or to be discontinued.

Current shortage
Clindamycin Phosphate Injection
Shortage listed since March 21, 2023
Manufacturer reports: 1 unavailable, 2 limited, 1 available
to be discontinued
Clindamycin Phosphate; Benzoyl Peroxide Gel
Shortage listed since August 1, 2025
to be discontinued
Clindamycin Hydrochloride Capsule
Shortage listed since February 25, 2026
to be discontinued
Clindamycin Palmitate Hydrochloride Injection
Shortage listed since February 27, 2026

See all current drug shortages

Chemical Identity

CAS18323-44-9

PubChem CID446598

DTXSIDDTXSID2022836

FormulaC18H33ClN2O5S

Mol. Weight425 g/mol

SMILESCCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl

Data Sources

PubChem · compound 446598Retrieved 2026-04-07
FDA National Drug Code directoryRetrieved 2026-04-25
FDA Drug ShortagesRetrieved 2026-10-04
US Census international tradeReporting year: 2024 · Retrieved 2026-10-04

← Back to Dashboard ← Back to Health

Brief citations

Clindamycin (CAS 18323-44-9) https://chemicalindependence.com/chemical/18323-44-9/ PubChem: 446598. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/446598 FDA National Drug Code directory: CAS 18323-44-9. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 18323-44-9. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 294190 for CAS 18323-44-9. Reporting year: 2024. https://usatrade.census.gov/